These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1038 related items for PubMed ID: 31230505

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q, Chen H, Zhang M, Xiong H, Jiang Q.
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X.
    Drug Des Devel Ther; 2017 Jul; 11():1115-1126. PubMed ID: 28435223
    [Abstract] [Full Text] [Related]

  • 25. High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.
    Li F, Wan X, Li Z, Zhou L.
    Cancer Med; 2024 Jun; 13(11):e7382. PubMed ID: 38872380
    [Abstract] [Full Text] [Related]

  • 26. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
    Ghanaatgar-Kasbi S, Amerizadeh F, Rahmani F, Hassanian SM, Khazaei M, Ferns GA, Avan A.
    IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.
    Zhang L, Huo X, Liao Y, Yang F, Gao L, Cao L.
    Sci Rep; 2017 May 10; 7(1):1669. PubMed ID: 28490807
    [Abstract] [Full Text] [Related]

  • 30. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
    Leu WJ, Swain ShP, Chan SH, Hsu JL, Liu SP, Chan ML, Yu CC, Hsu LC, Chou YL, Chang WL, Hou DR, Guh JH.
    Oncotarget; 2016 Nov 22; 7(47):76995-77009. PubMed ID: 27769069
    [Abstract] [Full Text] [Related]

  • 31. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A, Li H, Li R, Lu L, Wu X.
    Oncol Rep; 2018 Oct 22; 40(4):2353-2362. PubMed ID: 30066933
    [Abstract] [Full Text] [Related]

  • 32. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
    Sun X, Yang S, Song W.
    Biomed Pharmacother; 2020 Apr 22; 124():109731. PubMed ID: 31954876
    [Abstract] [Full Text] [Related]

  • 33. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D3 triple therapy against colon cancer cells by attenuating the PI3K/AKT/mTOR pathway.
    Idris S, Refaat B, Almaimani RA, Ahmed HG, Ahmad J, Alhadrami M, El-Readi MZ, Elzubier ME, Alaufi HAA, Al-Amin B, Alghamdi AA, Bahwerth F, Minshawi F, Kabrah SM, Aslam A.
    Life Sci; 2022 May 01; 296():120442. PubMed ID: 35245520
    [Abstract] [Full Text] [Related]

  • 34. Novel PI3K/Akt/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy.
    Wang J, Liang D, Zhang XP, He CF, Cao L, Zhang SQ, Xiao X, Li SJ, Cao YX.
    Int J Oncol; 2021 Jan 01; 58(1):70-82. PubMed ID: 33367926
    [Abstract] [Full Text] [Related]

  • 35. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 01; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
    Ji Y, Di W, Yang Q, Lu Z, Cai W, Wu J.
    Clin Lab; 2015 Aug 01; 61(8):1043-51. PubMed ID: 26427150
    [Abstract] [Full Text] [Related]

  • 37. Dual PI3K/mTOR Inhibitor BEZ235 combined with BMS-1166 Promoting Apoptosis in Colorectal Cancer.
    Liu X, Xu W, Li L, Zhang Z, Lu M, Xia X.
    Int J Med Sci; 2024 Aug 01; 21(10):1814-1823. PubMed ID: 39113885
    [Abstract] [Full Text] [Related]

  • 38. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
    Moench R, Grimmig T, Kannen V, Tripathi S, Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser AM, Gasser M.
    Oncotarget; 2016 Oct 18; 7(42):68749-68767. PubMed ID: 27626684
    [Abstract] [Full Text] [Related]

  • 39. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J.
    Cell Signal; 2014 Dec 18; 26(12):2782-92. PubMed ID: 25193113
    [Abstract] [Full Text] [Related]

  • 40. [Inhibition effect of active fraction from clove on PI3K/Akt/mTOR signaling pathway to induce apoptosis of human colon cancer HCT116 cells].
    Zhao G, Zhang D, Yang XH, Li XF, Liu MH.
    Zhongguo Zhong Yao Za Zhi; 2021 Mar 18; 46(5):1197-1204. PubMed ID: 33787115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.